Log In
BCIQ
Print this Print this
 

AIKO-151

  Manage Alerts
Collapse Summary General Information
Company Aiko Biotechnology Inc.
DescriptionOral neutral opioid antagonist
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationConstipation
Indication DetailsTreat opioid-induced constipation (OIC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today